Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Medicus Sciences Acquisition Corp.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
8-K
| Quarterly results |
| 01/18/2023 |
8-K
| Quarterly results |
| 03/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/15/2022 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/08/2022 |
8-K
| Quarterly results |
| 12/06/2021 |
8-K
| Quarterly results |
| 04/01/2021 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Medicus Sciences Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 5, 2021 New York, April 1, 2021 // -- Medicus Sciences Acquisition Corp. announced that, commencing April 5, 2021 , the units sold in the Company’ s initial public offering will no longer trade, and that the Company’ s Class A ordinary shares and the Company’ s redeemable warrants which together comprise the Units will commence trading separately. The Class A Ordinary Shares and the Redeemable Warrants will be listed on the Nasdaq Capital Market and trade under the ticker symbols, “MSAC” and “MSACW,” respectively. This is a mandatory and automatic separation, and no action is required by the holders of the Units. Each of the 92,000,000 Units sold in MSAC’ s initia..." |
|
| 02/24/2021 |
8-K
| Quarterly results |
| 02/19/2021 |
8-K
| Quarterly results |
|
|